gilteritinib-resistant FLT3 mutants [plasma membrane]

Stable Identifier
R-HSA-9699533
Type
Set [DefinedSet]
Species
Homo sapiens
Compartment
plasma membrane
Locations in the PathwayBrowser
Expand all
Literature References
PubMed ID Title Journal Year
27908881 Preclinical studies of gilteritinib, a next-generation FLT3 inhibitor

Levis, M, Nguyen, B, Smith, SC, Small, D, Raman, JR, Hernandez, D, Rajkhowa, T, Lee, LY

Blood 2017
32040554 Gilteritinib is a clinically active FLT3 inhibitor with broad activity against FLT3 kinase domain mutations

Perl, AE, Mori, K, Hill, JE, Tarver, TC, Bahceci, E, Smith, CC, Rahmat, L

Blood Adv 2020
Participants
members
Participates
as an input of
Disease
Name Identifier Synonyms
cancer DOID:162 malignant tumor, malignant neoplasm, primary cancer
Cite Us!